Long Term Mortality Rate in Patients Treated with Carotid Endarterectomy

Katarina Wadén1, Rebecka Hultgren2, Maria Ioanna Kotopouli3

  • 1Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Insights

Carotid endarterectomy (CEA) patients have similar long-term mortality whether symptomatic or not. However, men experienced worse outcomes than women, indicating a need for sex-specific secondary prevention strategies after CEA.

Area of Science:

  • Vascular Surgery
  • Stroke Prevention
  • Public Health

Background:

  • Carotid endarterectomy (CEA) is a key intervention for stroke prevention in patients with carotid stenosis.
  • Long-term mortality data in CEA patients are limited despite advancements in medical and surgical care.
  • Understanding long-term outcomes and identifying risk factors are crucial for optimizing patient management.

Purpose of the Study:

  • To evaluate the long-term all-cause mortality rate in patients who underwent CEA.
  • To compare mortality rates between asymptomatic and symptomatic patients.
  • To investigate sex differences in long-term mortality and identify factors influencing outcomes.

Main Methods:

  • A two-center, non-randomized observational study of 1,033 CEA patients (1998-2017).
  • Data on mortality and comorbidities were collected from national registries and medical records.
  • Cox regression analysis was used to assess associations between clinical characteristics and outcomes, including standardized mortality ratio (SMR).

Main Results:

  • Overall long-term mortality was similar for asymptomatic and symptomatic patients (34.2% vs. 33.7%).
  • Women had a lower crude mortality rate than men in the first 10 years post-CEA.
  • Increased SMR was observed in the first five years post-surgery, particularly in women and patients under 80.

Conclusions:

  • Long-term mortality after CEA is comparable for symptomatic and asymptomatic patients.
  • Significant sex differences in outcomes exist, with men facing worse prognosis.
  • Tailored secondary prevention strategies are essential to mitigate long-term adverse effects in CEA patients.
Abstract